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The generation of mitochondrial superoxide (O2.) by reverse
electron transport (RET) at complex I causes oxidative damage
in pathologies such as ischemia reperfusion injury, but also pro-
vides the precursor to H2O2 production in physiological mito-
chondrial redox signaling. Here, we quantified the factors that
determine mitochondrial O2. production by RET in isolated
heart mitochondria. Measuring mitochondrial H2O2 produc-
tion at a range of proton-motive force (p) values and for several
coenzyme Q (CoQ) and NADH pool redox states obtained with
the uncoupler p-trifluoromethoxyphenylhydrazone, we show
that O2. production by RET responds to changes in O2 concen-
tration, the magnitude of p, and the redox states of the CoQ
andNADHpools.Moreover, we determined how expressing the
alternative oxidase from the tunicate Ciona intestinalis to oxi-
dize the CoQ pool affected RET-mediated O2. production at
complex I, underscoring the importance of the CoQ pool for
mitochondrialO2. production byRET.An analysis ofO2. produc-
tion at complex I as a function of the thermodynamic forces
driving RET at complex I revealed that many molecules that
affect mitochondrial reactive oxygen species production do so
by altering the overall thermodynamic driving forces of RET,
rather than by directly acting on complex I. These findings clarify
the factors controlling RET-mediated mitochondrial O2. produc-
tion in both pathological and physiological conditions. We con-
clude that O2. production by RET is highly responsive to small
changes inp and the CoQ redox state, indicating that complex I
RET represents amajormode ofmitochondrial redox signaling.
Superoxide (O2. )3 is the proximal reactive oxygen species
(ROS) formed within mitochondria, with most O2. being very
rapidly converted toH2O2 bymanganese superoxide dismutase
(MnSOD) within the matrix (1, 2). As well as contributing to
oxidative damage, H2O2 acts as a redox signal, both within the
mitochondria and in the cytosol (3–6). This mode of signal
transduction arises via the reversible oxidation of protein thiols
that pass on the modification to effector proteins as a redox
relay (3–6).Whereas there are a number of potentialmitochon-
drial sources of O2. (2, 7, 8), respiratory chain complex I is con-
sidered to be a major contributor (1). The production of O2. at
complex I can be driven by reverse electron transport (RET) by
a highly reduced coenzyme Q (CoQ) pool and a large proton-
motive force (p), which together drive electrons backward
through complex I and lead to a dramatic increase in O2.
production (Fig. 1) (9). This process has been known since
the 1960s (10) but was tacitly assumed to be an in vitro curi-
osity of no physiological relevance (1, 11, 12). However, there
is now considerable evidence that RET at complex I is a
physiological process that underlies mitochondrial redox
signaling in a range of situations (11, 13) while also leading to
pathological oxidative damage during ischemia–reperfusion
injury (1, 14, 15).
A particularly intriguing aspect of RET is that it does not
require damage to, or inhibition of, the respiratory chain (1, 9).
As RET responds sensitively to physiological variables, O2. pro-
duction by complex I can be modulated under physiological
conditions (1, 9). Hence, there is considerable interest in under-
standing the mechanisms by which mitochondria regulate O2.
production at complex I by RET as a physiological signaling
process. Here, we quantified the factors that determine RET in
isolated heart mitochondria. To do this, we measured H2O2
generation as a function of the membrane potential () and
of the reduction state of the CoQ and NADH pools. This was
done by altering  with the uncoupler carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCCP) and also oxi-
dizing the CoQ pool by ectopic expression within heart
mitochondria of the alternative oxidase (AOX) from Ciona
intestinalis (16). Next, we assessed the dependence of RET
O2. production on O2 concentration, [O2], and last, we deter-
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mined how compounds known to alter mitochondrial ROS
production affect RET. Together, these data provide a com-
plete description of mitochondrial O2. production by RET
and indicate how this process contributes to oxidative dam-
age and redox signaling.
Results
Dependence of complex I O2
. production by RET onp and
CoQ redox state
To assess the factors that determineO2. production byRETat
complex I, we used isolated heart mitochondria. H2O2 efflux
frommitochondria is proportional to O2. production, assuming
that O2. is converted to H2O2 bymatrixMnSOD and that H2O2
degradation by peroxidases is similar across all conditions
assessed (1). Whereas H2O2 movement across the plasma
membrane is facilitated by aquaporins (17–19), these carriers
are not present in mitochondria (20); hence, H2O2 efflux is
probably unmediated, albeit facilitated by the large surface area
of the inner membrane. Thus, measuring H2O2 efflux enables
us to infer howO2. production by RET at complex I responds to
mitochondrial state.
Three factors are critical in determining O2. production by
RET: thep and the redox states of themitochondrial CoQ and
NADH pools (Fig. 1) (1). The O2 concentration is also likely to
affect O2. production (1); however, these experiments were in
air-saturated incubation medium ([O2] 200 M); the depen-
denceofO2. productionon[O2]wasdeterminedlater.Thedepen-
dence of mitochondrial H2O2 production on these three vari-
ables was measured in parallel (Fig. 2). p was measured as
 from the distribution of the lipophilic methyltriphenyl-
phosphonium (TPMP) cation (21) (Fig. 2B). Whereas this
does not measure the pH gradient (pH) across the inner
membrane, pH is a smaller (10–20%) component of p
than  and here is assumed to be invariant. The redox state
of the CoQ pool was assessed by measuring its percentage
reduction by reverse-phase HPLC (Fig. 2C). The redox state
Figure 1.Mitochondrial O2
. production from complex I by RET. The top panel shows conventional forward electron transport bymitochondria. The bottom
panel shows mitochondrial O2
. production by RET. This occurs when the p (a combination of the  and the pH) is high and the CoQ pool is reduced. Q,
ubiquinone; QH2, ubiquinol.
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of the NADH pool was inferred from NAD(P)H fluores-
cence. Although this cannot distinguish between NADH and
NADPH, the mitochondrial NADPH pool is thought to con-
tribute less to changes in this variable (22); hence, this
method gives a reasonable assessment of the NADH pool
redox state (Fig. 2D).
The addition of succinate to heartmitochondria led to exten-
sive H2O2 production (Fig. 2A), a large  (Fig. 2B), and highly
reducedCoQ (Fig. 2C) andNAD(P)H (Fig. 2D) pools. The addi-
tion of the complex I inhibitor rotenone decreased H2O2 pro-
duction without affecting  (Fig. 2B) or the CoQ pool (Fig.
2C), but there was oxidation of the NAD(P)H pool (Fig. 2D).
These findings are consistent with H2O2 production originat-
ing from complex I by RET (1). To explore the dependence of
RETon and the redox state of theCoQandNAD(P)Hpools,
we measured these variables with increasing amounts of the
uncoupler FCCP. The gradual decrease in H2O2 production
that resulted (Fig. 2A) was associatedwith a decrease in (Fig.
2B) and oxidation of the CoQ (Fig. 2C) and NAD(P)H (Fig. 2D)
pools.
The matrix pH has been suggested to alter RET directly at
complex I, independently of its role as the pH component of
p (23, 24). Hence, we next used the K/H exchanger nigeri-
cin to decrease the matrix pH from7.7 to that of the incuba-
tion medium (pH 7.4), thereby abolishing the pH component
ofp. Importantly, themagnitude ofpwill not change, due to
a compensatory increase of20 mV in  (Fig. 2B). Nigericin
resulted in an oxidation of the CoQ (Fig. 2C) and NAD(P)H
pools (Fig. 2D) and a decrease in H2O2 efflux (Fig. 2A).
Together, these data show a strong dependence of RET at com-
plex I on the magnitude of p and on the CoQ and NAD(P)H
redox states.
Effect of the AOX onO2
. production by RET
To analyze the effects of CoQpool redox state onO2. produc-
tion by RET, independently of effects on p, we utilized mice
expressing the AOX from C. intestinalis (16). AOX transfers
electrons from CoQH2 directly to O2, bypassing complex IV,
and thus acts as a safety valve to prevent the excessive reduction
of the CoQpool (25, 26). TheAOXprotein was present in heart
mitochondria from AOX/ knock-in mice (Fig. 3A) and was
catalytically active, as respiration in mitochondria from WT
mice was inhibited by cyanide, whereas mitochondria from
AOX mice continued to respire, but this residual respiration
was sensitive to the AOX inhibitor N-propyl gallate (Fig. 3B).
Mitochondrial H2O2 efflux during succinate oxidation was
decreased by AOX expression as shown previously (16) (Fig.
3C). Thiswas not due to a decrease in (Fig. 3D); however, the
CoQ pool was more oxidized inmitochondria containing AOX
(27) (Fig. 3E). These findings show that the expression of AOX
affects O2. production by RET at complex I by oxidizing the
CoQ pool and further support the importance of CoQ pool
redox state in determining mitochondrial O2. production by
RET.
Effect of [O2] on O2
. production by complex I RET
As the generation of O2. by mitochondria requires that O2
react with a protein-bound electron carrier, the rate of O2. pro-
duction will probably depend on the [O2] (1). To assess this
dependence, wemeasuredmitochondrial H2O2 efflux at differ-
ent [O2] (Fig. 4). As the apparent Km of cytochrome oxidase for
O2 is very low ( 1M) (28),p and the redox state of the CoQ
and NADH pools will not vary with [O2]. The assessment of
H2O2 efflux at different [O2] relies on the conversion ofAmplex
Red to its fluorescent product resorufin catalyzed by horserad-
ish peroxidase (HRP); hence, we first demonstrated that the
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Figure 2. Parallel measurement of mitochondrial H2O2 efflux, , and
the redox status of the NAD(P)H and CoQ pools. Rat heart mitochondria
were incubated in the presence of potassium succinate. Where indicated,
FCCP, nigericin (1 M), or rotenone (5 M) was added, and the indicated vari-
ables were measured. A, H2O2 efflux. B, . C, CoQ redox status. D, NAD(P)H
redox status. Data are the mean  S.E. (error bars) from 3–4 independent
mitochondrial preparations. *, p 0.05 comparedwith succinate-only condi-
tions by ANOVA.
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fluorescence of resorufin (Fig. 4A, inset) and the conversion of
Amplex Red to resorufin (Fig. 4A) were both independent of
[O2]. We then measured mitochondrial H2O2 generation by
RET and showed that it was proportional to [O2] and was abol-
ished by excess FCCP (Fig. 4B). In contrast, production ofH2O2
by NADH-linked substrates in the presence of rotenone (Fig.
4C) or from complex III upon inhibition of succinate respira-
tion by antimycin (Fig. 4C) also showed increased H2O2 pro-
duction with [O2], but in this case ROS production reached a
plateau as [O2] increased. Thus, production of O2. by RET at
complex I is proportional to [O2].
Effects of therapeutic compounds on complex I RET
Anumber of potentially therapeutic compounds are thought
to act, at least in part, by decreasing mitochondrial ROS pro-
duction. Therefore, we set out to assess some of these com-
pounds to determine whether they altered RET at complex I.
The compounds tested were as follows: MitoQ, a mitochon-
dria-targeted antioxidant based on ubiquinone (29); decylTPP,
which contains the mitochondria-targeting triphenylphospho-
nium (TPP) cation and which is frequently used as a control
compound to correct for nonspecific effects of MitoQ (21);
SS31, a peptide composed of D-Arg-Dmt-Lys-Phe-NH2 (30)
(whereDmt represents 2,6-dimethyltyrosine), whose therapeu-
tic effects are thought to be due to its interactions with mito-
chondria; CN-POBS, an inhibitor of mitochondrial O2. produc-
tion by RET at complex I (12); and the antidiabetic biguanides
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Figure 3. Effect of AOX expression onmitochondrial H2O2 production. A,
AOX expression in mouse heart mitochondria. Heart mitochondria from
AOX/ mice or WT littermate controls were analyzed by Western blotting
for AOX using the mitochondrial outer membrane protein voltage-depen-
dent anion channel as a loading control. Mitochondria from three separate
AOX/ and WT mice were assessed. B, O2 consumption by mitochondria
from AOX/ and WT mice. Mitochondria (200 g of protein/ml) were incu-
bated at 37 °C in an oxygen electrode and respiration was initiated by the
addition of succinate (10 mM) followed by KCN (1 mM) and propyl gallate
(50 M). Traces are typical of experiments repeated with at least three
independent mitochondrial preparations for each condition. C, H2O2 pro-
duction by heart mitochondria from AOX/ and WT mice. Mitochondria
(200 g of protein/ml) were incubated with succinate (10 mM), and H2O2
production was assessed. n 3 (WT) or 6 (AOX). D,  of heart mitochon-
dria from AOX and WT mice. Mitochondria (500 g of protein/ml) were
incubated at 37 °C for 5 min with succinate (10 mM), and was assessed.
n  4. E, CoQ redox state of heart mitochondria from AOX and WT mice.
Mitochondria (1 mg of protein/ml) were incubated at 37 °C for 2 min with
succinate (10mM), and the CoQ redox statewas assessed. n 4. *, p 0.05;
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Figure 4. Dependence onmitochondrial H2O2 generation on [O2]. A, con-
version of Amplex Red to resorufin by HRP at different [O2]. The [O2] of KCl
buffer containing Amplex Red, HRP, and SOD was decreased by bubbling
with N2. Then known amounts H2O2 were injected, and fluorescence was
measured. The inset shows the fluorescence of resorufin (25 M), which was
added to an incubation of mitochondria respiring on succinate in the pres-
ence of rotenone (5M), and resorufin fluorescencewasmeasured as the [O2]
decreased due to mitochondrial respiration. B, dependence on [O2] of mito-
chondrial H2O2 generation by RET. Rat heart mitochondria were incubated in
an oxygen electrode, and H2O2 generation was measured at various [O2] set
by bubbling with N2, and ROS production was measured over a dynamic
range ofO2 tensions.Where indicated, 500 nM FCCPwas present. Data are the
meanS.E. (error bars).n11.C, comparisonof [O2] dependenceofdifferent
modes of mitochondrial H2O2 generation. Mitochondria were assessed as in
B, except that the respiratory substrate was glutamate/malate (5mM each) in
the presence of rotenone (4g/ml). n 6, ormitochondriawere respiring on
succinatewith antimycin (1M) present. Data are themean S.E. (n 5) and
compared with the trace from C.
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metformin and phenformin, which are known to interact with
complex I (31, 32).
We first assessed whether these compounds affected H2O2
efflux by RET at complex I. All of the compounds, except SS31,
decreasedmitochondrial O2. production by RET to some extent
(Fig. 5A). As RET at complex I is very sensitive to themagnitude
of  and redox state of the CoQ pool, these compounds may
affect RET indirectly by altering these bioenergetic variables
rather than by directly interactingwith complex I to blockRET-
dependent O2. production. Consistent with this interpretation,
all of the compounds decreased (Fig. 5B), and some affected
the redox states of the CoQ and NAD(P)H pools (Fig. 5, C and
D). Together, these findings suggest that the effects of these
compounds on RET at complex I may be indirect due to effects
on  and perhaps on the redox states of the NAD(P)H and
CoQ pools.
Dependence of RET on and the redox state of the CoQ pool
Measuring H2O2 production by mitochondria in parallel
with  and the redox state of the CoQ pool indicated that
O2. production by RET at complex I was very sensitive to both
variables (Figs. 2 and 3). To illustrate the dependence of RET on
 and redox state of the CoQ pool, we replotted the data
from Fig. 2 to show H2O2 production as a function of both
 and CoQ redox state (Fig. 6). This 3D plot makes evident
the very steep dependence of H2O2 production on  and on
CoQ redox state, confirming the exquisite sensitivity of O2.
production by RET at complex I to these two physiological
variables.
The thermodynamic driving force for RET at complex I
Whereas Fig. 6 shows clearly that decreasing  and oxidiz-
ing the CoQ pool lowers RET, it does not provide a quantitative
basis to allow us to infer whether the effects of nigericin shown
in Fig. 2A and those of the various compounds shown in Fig. 5A
are due to direct interactions with complex I itself or are
indirect effects due to altering the driving forces of RET.
Therefore, we next determined how O2. production during
RET depends on the overall thermodynamic driving force
across complex I.
The direction of electron flow at complex I is determined by
the balance of thermodynamic driving forces across the com-
plex (Fig. 1). During forward electron transfer at complex I, two
electrons are passed from NADH to CoQ.
NADH  CoQ 7 NAD  CoQH2
Reaction 1
The driving force for the transfer of two electrons from
NADH to CoQ is Eh.
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Eh  EhNADNADH Eh CoQCoQH2 (Eq. 1)
This driving force, 2Eh, is used to pump four protons across
the mitochondrial inner membrane against the p. Hence, for
forward electron movement to occur, the thermodynamic
requirement is as follows.
2Eh  4p (Eq. 2)
However, when the p is high and/or the Eh is decreased,
RET can occur provided the following is true.
2Eh  4p (Eq. 3)
Wecan thus calculate the thermodynamic driving force (G)
for RET, where F is the Faraday constant (33).
G  2FEh  4Fp (Eq. 4)
Rearranging to express the thermodynamic driving force for
RET as a positive number in V gives the following.
G/F 4p 2Eh (Eq. 5)
From this, we can use the data from the FCCP titration in Fig.
2 to calculate G/F, the driving force for RET (see “Experi-
mental procedures”). This analysis yields a plot of H2O2
production by RET as a function of the thermodynamic driv-
ing force across complex I (Fig. 7A). This shows that when
G/F  0, there is a residual background level of ROS pro-
duction, but as soon as the driving force for RET passes a
threshold and G/F 	 0, there is a dramatic and steep
increase in O2. production by RET. This analysis confirms that
theO2. production by RET requires a sufficient thermodynamic
force to reverse electron transport at complex I and further
shows the steep dependence of O2. production on this driving
force.
A benefit of describing H2O2 production by RET at complex
I as a function of its overall thermodynamic driving force is that
it enables us to quantify whether compounds that affect O2.
production by RET do so by altering the drivers of this process
or by acting directly on complex I. A compound that only
affects O2. production by RET indirectly through altering p
and Eh would lie on the curve shown in Fig. 7A. In contrast, a
compound that directly affected complex I independently of
the thermodynamic drivers of RET, would lie below this curve.
We first applied this analysis to nigericin, which decreases
H2O2 production by RET (Fig. 2A) but which also led to a more
oxidized CoQ pool (Fig. 2C) without affectingp. Carrying out
this analysis, including accounting for changes in matrix pH on
Eh of the NADH and CoQ pools (see “Calculations”) indicated
that the decrease inH2O2 production by nigericinwas due to its
effects on the CoQ pool redox state (Fig. 7A). In contrast, the
decrease of H2O2 production by the complex I inhibitor rote-
none (Fig. 2A) was not due to changes in the thermodynamic
driving forces for RET, as these data lay below the trend line in
Fig. 7A.
If the compounds that affect mitochondrial ROS production
assessed in Fig. 5 decreasemitochondrial ROSproduction inde-
pendently of the drivers of RET, then they should lie below the
trend line shown in Fig. 7A, as was the case for rotenone.When
the data from Fig. 5 were analyzed to show the effect of these
compounds on the thermodynamic driving forces for RET,
the results lay above the trend line, showing the dependence
of H2O2 production on the thermodynamic driving forces
across complex I (Fig. 7B). Hence, these data suggest that the
effects of the compounds analyzed in Fig. 5 on ROS produc-
tion by RET are more likely to be accounted for by their
effects on p and/or Eh rather than due to specific inhibi-
tory effects on complex I.
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Discussion
We investigated the dependence of O2. production by RET at
complex I within isolated mitochondria on Eh of the NAD(P)H
and CoQ pools, p, matrix pH, and [O2]. This approach con-
firmed that O2. production by RET at complex I is favored by a
high p and a reduced CoQ pool, with exquisite sensitivity to
small changes in these two drivers (Fig. 6). This analysis was
extended to show that O2. production by RET at complex I was
also highly responsive to small changes in the overall thermo-
dynamic driving force for RET across the complex (Fig. 7A).
Two sites have been proposed for O2. production by complex
I during RET: the FMNof the complex I NADH-binding site (9,
34, 35) or the CoQ-binding site (36, 37).We favor the FMN site
as the source ofO2. production by complex I during RET. This is
because the penetration of O2 to the CoQ site is difficult to
envisage from the structure of complex I (38, 39). In addition,
the generation of the negatively charged O2. from the CoQ site
would require its thermodynamically unfavorable formation
within the hydrophobic core of the membrane bilayer (38, 39).
Furthermore, the FMN site is well established as a source of
O2. production by rotenone-inhibited complex I (38, 39). Dur-
ing this process, NADH reduces the FMN to FMNH, which is
then readily accessed byO2 to formO2. (38, 39). In addition, any
O2. formed at this site is released directly into the aqueous phase
(9, 35, 40). The relationship between [O2] and RET was linear
over the physiological [O2] range, consistent with O2. produc-
tion being driven by the second-order reaction betweenO2 and
FMNH on complex I when it is free from bound NAD or
NADH (9, 35, 40).
During rotenone inhibition, the FMN/FMNH ratio is set by
a rapid pre-equilibration with the matrix NAD/NADH pool
and thereby determines the rate of O2. production (9, 35). We
favor FMNH as the donor of an electron to O2 for O2. produc-
tion by complex I during RET. However, if this is the case then
the greater O2. production during RET compared with rote-
none-inhibited complex I has to be explained, because under
both conditions, O2. production is determined by the FMN/
FMNH ratio (9, 23, 24, 37). The most likely reason why RET-
driven O2. production is greater than that upon rotenone inhi-
bition is because the large thermodynamic driving force for
electron movement backward through complex I during RET
holds the FMN/FMNH ratio at a more negative Eh than is
possible by equilibrium with the NAD/NADH pool (9). The
more negative midpoint potential of the FMN/FMNH couple
(Em,7.5  380 mV) (41) compared with the NAD/NADH
couple (Em,7.5  335 mV) is consistent with this hypothesis.
Other factors that could contribute to the elevated O2. produc-
tion during RET compared with rotenone inhibition include
differential access ofO2 to the FMNH due to alterations in the
NADH and NAD binding or differences in the activity of the
peroxidases that degrade H2O2 within the mitochondrial
matrix.One further consideration is that duringO2. production,
FMNH donates one electron to O2 to form a semiquinone
radical, FMN, which is then thought to rapidly redistribute its
unpaired electron throughout the iron–sulfur centers on com-
plex I (40). However, the FMN radical also reacts very rapidly
with O2 to form O2. , so if electron redistribution were slowed
during RET, the enhanced lifetime of FMNwould also enhance
O2. production (40).
A further point to note is that the term RET is often inter-
preted as requiring NAD reduction at the FMN site of com-
plex I. This is not the case, as O2. production by RET at complex
I occurs when the NAD/NADH pool is highly reduced and
there is no net electron flow from complex I into this pool (e.g.
Fig. 2D). Thus, we favor a model in which O2 reacts with a
FMNH to generate O2. , whereas the FMN still exchanges elec-
trons with the matrix NAD/NADH pool, although there is no
net electron transfer (Fig. 8).
The generation ofO2. by RET at complex I could be described
as a function of the thermodynamic driving forces,p andEh,
across the complex. As well as illustrating the factors that drive
RET, this analysis allowed us to integrate the effects of the
forces driving RET. Applying this to the decrease in RET when
the matrix pH decreased suggested that the lower rate of RET
could be accounted for by the change in the Eh between the
CoQ and NADH pools and may not be due to a direct effect of
pH on complex I itself (24). Furthermore, this approach sug-
gests that compounds such asMitoQ andmetformin that affect
mitochondrial ROS metabolism may do so indirectly, rather
than by specific interactions with complex I. However, it is
important to note that the calculation of G/F requires a
number of assumptions and combines several technically chal-
lenging experimental measurements; hence, systematic errors
will affect accuracy and precision. In addition, we have assumed
that the CoQ pool interacts to the same extent with all com-
plexes, and any effects of supercomplex formation on this were
not considered (42). Nevertheless, ourwork does indicate novel
approaches for determining how compounds impact mito-
chondrial ROS production and has implications for the inter-
pretation of experiments using these compounds. For example,
MitoQ is widely used in vitro and in vivo, where it acts as a
chain-breaking antioxidant decreasing oxidative damage (29,
43). As the excessive accumulation of hydrophobic TPP com-
pounds disrupts mitochondrial function (44, 45), controls with
compounds with matched physicochemical properties are
essential to correct for nonspecific effects. Thus, some “antiox-
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idant” effects of lipophilic cations may be due to mild disrup-
tion of p that lowers mitochondrial O2. production by RET.
Similarly, some of the beneficial effects of less hydrophobic cat-
ions, such asmetformin in vivo, may be associatedwith limiting
O2. production by RET, in addition to stimulating AMP-acti-
vated protein kinase by inhibiting complex I (46, 47).
Mitochondrial O2. production by RET was initially investi-
gated in vitro, and at that time its relevance to in vivo physiology
was not considered (10). Recently, mitochondrial ROS produc-
tion by RET has been demonstrated in multiple situations in
vivo. For example, during ischemia, high levels of succinate
accumulate, and it is oxidized upon reperfusion to drive a burst
of ROS via RET (14, 48). More generally, RET at complex I
occurs as a redox-signaling pathway in inflammation (13), con-
tributes to lifespan in flies (49), and is part of the oxygen-sens-
ingmechanism of the carotid body (49). The linear dependence
of ROS production by RET on O2 (Fig. 4), which has been
shown previously by others (50–53), further adds to its appeal
as a potential component of the carotid body O2 sensor (49).
One possibility is that O2. production by RET at complex I
accounts for most of the redox signaling from the mitochon-
drion to the rest of the cell (3–6). The appeal of RET as a mito-
chondrial redox signal is illustrated in Figs. 6 and 7, which show
the tremendous sensitivity of RET top and the redox status of
the CoQ pool. The magnitude of p is directly linked to ATP
demand, whereas the redox state of the CoQ pool reflects elec-
tron supply to the respiratory chain. Thus, RET provides a sen-
sitive mechanism for the real-time feedback of themost critical
aspects of mitochondrial status to the rest of the organelle and
to the cell (Fig. 8).
In summary, we have provided a thermodynamic underpin-
ning to O2. production by RET at complex I. This analysis high-
lights the potential for this mechanism to play a key role in
mitochondrial redox signaling and demonstrates how to inves-
tigate the effects of RET on various physiological and patholog-
ical processes.
Experimental procedures
Mitochondria isolation
All procedures were performed in accordance with the UK
Guide for the Care and Use of Laboratory Animals (PPL:
70/7538). Rat hearts were collected from 10–12-week-old
female Wistar rats (Charles River). C57Bl/6 mice carrying a
single copy of the C. intestinalis AOX gene in the Rosa26 locus
were generated as described (16). AOX mice and their WT
littermate controls of both sexes were used at 8–12 weeks of
age to prepare heart mitochondria. Rats were killed by stun-
ning followed by cervical dislocation. Mice were killed by
cervical dislocation only. Hearts were removed into ice-cold
STE buffer (250 mM sucrose, 5 mM Tris-HCl (pH 7.4, KOH),
and 1 mM K-EGTA, supplemented with 0.1% (w/v) fatty
acid–free BSA. Heart mitochondria were isolated by homog-
enization and differential centrifugation (700 
 g for 3 min;
3 
 5,500 
 g for 10 min) at 4 °C. Mitochondrial protein
content was determined using the bicinchoninic acid assay
with BSA as a standard.
Hydrogen peroxide efflux
H2O2 efflux from mitochondria was assayed using a plate
reader fluorometer (SpectraMax GeminiXS, Molecular Devic-
es; used at medium sensitivity). Resorufin (the product of
Amplex Red oxidation) fluorescence was detected using ex
570 nm and em  585 nm. Mitochondria (2 mg protein/ml)
were incubated with 2.5 M Amplex Red (Invitrogen), 5
units/ml HRP in STE with 10mM potassium succinate at 37 °C.
H2O2 production rates were linear over 10 min but were mea-
sured from 0 to 2 min to facilitate comparison with other mea-
surements. The H2O2 response was calibrated using freshly
prepared H2O2 standards (	240  43.5 M1 cm1) that were
added sequentially to mitochondrial incubations lacking only
succinate to generate a linear calibration curve. Mitochondria-
targeted test compounds were added 30 s beforemeasurement.
Mitochondrial
Mitochondrial 	 was measured by the uptake of radiola-
beled [3H]TPMP as described (21). Mitochondria (2 mg pro-
tein/ml) were incubated at 37 °C with 10 mM succinate, 500 nM
TPMP supplemented with [3H]TPMP (50 nCi/ml) with the test
compounds for 2 min in 250 l of medium in Eppendorf tubes.
Mitochondria were pelleted by centrifugation (10,000 
 g for
30 s). Supernatant (200 l) was removed, and the pellets were
driedwith a rolled-up tissue and then solubilized in 40l of 20%
(v/v) Triton X-100. Both the supernatant and pellets were then
added to scintillant (Ultima-Gold liquid scintillant, Perkin-
Elmer Life Sciences) and incubated for 1 h at room temperature
and then vortexed, and [3H]TPMP content was assessed using a
TriCarb LCS counter (PerkinElmer Life Sciences) counter with
appropriate quench controls. To calculate the	, first the accu-
mulation ratio was calculated assuming amitochondrial matrix
volume of 0.6 l/mg protein, and the mitochondrial 	 was
then calculated from the Nernst equation, assuming 40% bind-
ing of TPMP and that this was independent of mitochondrial
	 and consistent across all conditions (21).
CoQ extraction and detection
Mitochondria (2 mg of protein/ml) were incubated in 500–
700 l of STE with 10 mM potassium succinate at 37 °C on a
shaking heat block for 2 min. At the end of the incubation,
mitochondria were rapidly pelleted by centrifugation (10,000

g for 30 s), the supernatant was removed, and pellets were snap-
frozen in a dry ice/ethanol bath and stored at80 °C until anal-
ysis. Immediately before HPLC analysis, the pellets were
homogenized in 0.5ml of ice-cold, nitrogen-purged 1-propanol
in an ice-cold glass-on-glass homogenizer, 100 l of ice-cold
H2O was added, and the samples were centrifuged (16,000
 g
at 4 °C for 5min). Supernatants (200l) were immediately ana-
lyzed by HPLC on a 150
 4.6-mm, 3  Hypersil ODS column
(Thermo). Solvent AwasMeOH, 50mMNaClO4; solvent Bwas
EtOH, 50 mM NaClO4. The gradient was 60% to 50% A over 15
min at a flow rate of 0.8 ml/min at 45 °C. Identity was estab-
lished by retention time compared with authentic standards at
the absorbance maxima for CoQ and CoQH2 (260 and 290 nm,
respectively). CoQ9 redox state was determined from the peak
areas of ubiquinone and ubiquinol at 292.5 nm, the isosbestic
point for oxidized and reduced CoQ9. The percentage reduc-
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tion of theCoQ9 poolwas calculated as area of the reduced peak
divided by the sum of both peak areas. Control incubations
under conditions designed tomaximally oxidize and reduce the
CoQpool demonstrated that this approach accurately reported
the CoQ redox state, as the percentage reduction increased to
80% in the presence of cyanide or anoxia, whereas inhibition
of the respiratory chain withmalonate decreased the percent-
age reduction to 20%.
Redox state ofmitochondrial NAD(P)H/NAD(P) pools
The redox state of the NAD(P)H/NAD(P) pool was deter-
mined by monitoring NAD(P)H fluorescence using a plate
reader fluorimeter (SpectraMax GeminiXS; Molecular Devices)
using ex  365 nm and em  450 nm. Mitochondria were
incubated as described for measuring H2O2 efflux. The signal
was calibrated by subtraction of background fluorescence
(mitochondria with no additions), and maximal reduction of
the pool was set by incubating mitochondria with 5 mMmalate
and 5 M rotenone for 5 min.
Combined respirometry and H2O2 productionmeasurements
Combined respiration and H2O2 production by mitochon-
dria was assessed using an Oxygraph2K (O2K) respirometer
(Oroboros, Innsbruck, Austria) with a fluorescence LED mod-
ule attachment. To assess the effect of O2 concentration on
H2O2 production, mitochondria (200–250 g of protein/ml)
were suspended in 2 ml of KCl buffer (120 mM KCl, 10 mM
Hepes, 1 mM EGTA, pH 7.2) supplemented with 50 units/ml
SOD, 4 units/ml HRP, 0.2 mg/ml fatty acid–free BSA, 25 M
Amplex Red with stirring at 37 °C. Respiration was initiated by
the addition of either 5 mM glutamate and 5 mMmalate; 10 mM
succinate; or 10mM succinate with 5M rotenone.Where indi-
cated, incubations were supplemented at the start with 5 M
rotenone, 500 nM FCCP, 1 M antimycin A, or 1 M nigericin.
The concentration of O2 was adjusted by bubbling the buffer
with N2. Amplex Red fluorescence was measured via the O2K
fluorometer, and the corresponding voltage changes were cali-
brated via titration of known amounts ofH2O2 (500 nM to 5M)
in the presence of mitochondria, SOD, fatty acid–free BSA,
HRP, and Amplex Red.
Western blotting
Mitochondrial pellets (250 g of protein) were solubilized
on ice in 50l of lysis buffer (100mMTris, 300mMNaCl, 0.05%
Nonidet P-40, pH 7.4, supplemented with protease and phos-
phatase inhibitors (Roche Applied Science). Protein was then
quantified by the BCA assay and diluted in 4
 loading buffer
(Invitrogen), and 10g of protein was separated by SDS-PAGE
on a 10% gel and transferred to polyvinylidene difluoridemem-
brane. Membranes were incubated with a 1:20,000 dilution of
rabbit serum raised against two AOX peptides (FKIETNDST-
DEPNIEVENFPC and CVNHDLGSRKPDEQNPYPPGQ (49))
and a mouse monoclonal antibody against the voltage-depen-
dent anion channel (1:1,000; Abcam ab14734)) and visualized
using a LI-COR Odyssey flatbed scanner with anti-mouse and
anti-rabbit secondary antibodies conjugated to IRDye 680RD
and IRDye 800CW, respectively.
Calculations
This section describes calculations required to determine the
thermodynamic driving force for RET from the data in Figs. 2
and 5 to generate the graphs shown in Fig. 7. The thermody-
namic driving force for RET is derived from Equation 5. In mV,
it is as follows.
p   61.5pH (Eq. 6)
In the presence of nigericin, p is unchanged, whereas
pH  0. Hence, pH   (nigericin)   (nigericin).
From Fig. 2C, 61.5pH18.1 mV and the matrix pH 7.7.
p  
 18.1 (Eq. 7)
As the matrix pH is 7.7, Eh for the NAD/NADH couple in
mV is as follows.
EhNAD
/NADH341
 30.5log10NAD
/NADH
(Eq. 8)
In the presence of nigericin, the matrix pH will be 7.4, and
under those conditions, the following will be true.
EhNAD
/NADH332
 30.5log10NAD
/NADH
(Eq. 9)
As thematrix pH is 7.7,Eh for theCoQ/CoQH2 couple inmV
is as follows.
EhCoQ/CoQH238
 30.5log10CoQ/CoQH2
(Eq. 10)
In the presence of nigericin, the matrix pH will be 7.4, and
under those conditions, the following will be true.
EhCoQ/CoQH220
 30.5log10CoQ/CoQH2
(Eq. 11)
Statistical analysis and experimental design
Data were expressed asmean S.E., with p values calculated
using a two-tailed Student’s t test for pairwise comparisons
whereas one-way analysis of variance (ANOVA) followed by
Tukey’s post hoc test was used for multiple comparisons. Sta-
tistical analyses were performed using GraphPad Prism version
7 software.
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